Inactivation of substance P and its C-terminal fragments in rat plasma and its inhibition by Captopril

Canadian Journal of Physiology and Pharmacology
R Couture, D Regoli

Abstract

The metabolic degradation of substance P(SP), some of its C-terminal fragments, and some analogues by rat plasma has been evaluated from the disappearance of the biological activities of these peptides on the guinea pig isolated ileum. The experiments were performed by dissolving each peptide in saline and by adding 20% (v/v) of rat plasma for incubation at 37 degrees C for various periods of time. It was found that SP and octapeptide 4-11 are inactivated quite rapidly and at approximately the same rate whereas SP-free acid, heptapeptide 5-11, hexapeptide 6-11, and [D-Trp8]-SP are inactivated more slowly. The replacement of Phe7 by D-Trp does not protect the undecapeptide SP from inactivation. The degradation of SP and of all the C-terminal fragments was completely blocked by Captopril at a concentration of 10 micrograms/mL of plasma. Under these conditions, Captopril also slightly reduced the rate of inactivation of bradykinin and of SP-free acid. These results were interpreted as indicative of the presence in rat plasma of an endopeptidase that hydrolyses a peptide bond in the C-terminal pentapeptide sequence of SP. This endopeptidase is completely inactivated by Captopril, which thus appears to be not as specific for the ang...Continue Reading

Citations

Aug 2, 1990·European Journal of Pharmacology·L Jacques, R Couture
Dec 1, 1983·Regulatory Peptides·J M Conlon, L Sheehan
May 1, 1991·Pharmacology & Toxicology·U RosenqvistR G Andersson
Jan 1, 1990·The Journal of Clinical Investigation·M A MartinsJ M Drazen
Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·R A Skidgel, E G Erdös
Aug 18, 2004·Behavioural Brain Research·Filipe S DuarteThereza C M De Lima
Jun 21, 2005·Experimental Neurology·H H KrämerF Birklein
Mar 18, 2017·The Journal of Headache and Pain·Wendy Sophie SchouMessoud Ashina
Nov 9, 2000·Clinical and Experimental Pharmacology & Physiology·E N PatakM E Story
Oct 1, 1985·Medicinal Research Reviews·M J Wyvratt, A A Patchett
Jul 1, 1989·Hypertension·T BergJ M Stewart
Jun 1, 1993·Journal of Neurochemistry·C J MussapE Burcher
Sep 1, 1989·Medical Toxicology and Adverse Drug Experience·B R Lindgren, R G Andersson
Jan 1, 1984·Acta Pharmacologica Et Toxicologica·K DelinH Herlitz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.